Peri- and Post-procedural Anticoagulation with Left Atrial Appendage Occlusion Devices.

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Heart International Pub Date : 2023-06-21 eCollection Date: 2023-01-01 DOI:10.17925/HI.2023.17.1.54
Pradyumna Agasthi, Sai Harika Pujari
{"title":"Peri- and Post-procedural Anticoagulation with Left Atrial Appendage Occlusion Devices.","authors":"Pradyumna Agasthi, Sai Harika Pujari","doi":"10.17925/HI.2023.17.1.54","DOIUrl":null,"url":null,"abstract":"<p><p>In patients with atrial fibrillation and high stroke risk, anticoagulation with direct oral anticoagulants or vitamin K antagonists is the standard of care for stroke prevention. The benefit of anticoagulation is driven by attenuating the risk of thrombus formation in the left atrial appendage. Percutaneous left atrial appendage occlusion offers an alternative therapeutic strategy for stroke prevention in patients with high bleeding risk or contraindications for long-term anticoagulation. This review of the current literature delineates the standard protocols of peri- and post-procedural anticoagulation/antithrombotic therapy after left atrial appendage occlusion, the complications of the procedure, and the risk of device-related thrombosis and of incomplete occlusion of the appendage. Finally,the limitations and gaps in the literature are identified.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"17 1","pages":"54-59"},"PeriodicalIF":1.9000,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339453/pdf/touchcardio-17-1-54.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/HI.2023.17.1.54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

In patients with atrial fibrillation and high stroke risk, anticoagulation with direct oral anticoagulants or vitamin K antagonists is the standard of care for stroke prevention. The benefit of anticoagulation is driven by attenuating the risk of thrombus formation in the left atrial appendage. Percutaneous left atrial appendage occlusion offers an alternative therapeutic strategy for stroke prevention in patients with high bleeding risk or contraindications for long-term anticoagulation. This review of the current literature delineates the standard protocols of peri- and post-procedural anticoagulation/antithrombotic therapy after left atrial appendage occlusion, the complications of the procedure, and the risk of device-related thrombosis and of incomplete occlusion of the appendage. Finally,the limitations and gaps in the literature are identified.

左心房阑尾闭塞器手术前后的抗凝治疗。
对于心房颤动和中风风险较高的患者,使用直接口服抗凝剂或维生素 K 拮抗剂进行抗凝是预防中风的标准疗法。抗凝的益处在于降低左心房阑尾血栓形成的风险。对于出血风险高或有长期抗凝禁忌症的患者,经皮左房阑尾封堵术为预防卒中提供了另一种治疗策略。这篇对当前文献的综述描述了左心房阑尾封堵术后围手术期和术后抗凝/抗血栓治疗的标准方案、手术并发症、与器械相关的血栓形成和阑尾不完全封堵的风险。最后,还指出了文献的局限性和不足之处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart International
Heart International Medicine-Cardiology and Cardiovascular Medicine
CiteScore
0.90
自引率
0.00%
发文量
9
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信